Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany†

PURPOSE: A prospective, epidemiologic study was conducted to assess whether the 2009 pandemic influenza A(H1N1) vaccination in Germany almost exclusively using an AS03-adjuvanted vaccine (Pandemrix) impacts the risk of Guillain–Barré syndrome (GBS) and its variant Fisher syndrome (FS). METHODS: Pote...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharmacoepidemiol Drug Saf
Auteurs principaux: Prestel, Jürgen, Volkers, Peter, Mentzer, Dirk, Lehmann, Helmar C, Hartung, Hans-Peter, Keller-Stanislawski, Brigitte
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2014
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282476/
https://ncbi.nlm.nih.gov/pubmed/24817531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3638
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires